| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002016432A3 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 09/04/2003 | WO2002008456A3 Method for identifying metastatic tumor cells |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | US20030167534 Method of producing heteromultimeric mammalian proteins in plants |
| 09/04/2003 | US20030167502 Human monoclonal antibodies to dendritic cells |
| 09/04/2003 | US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences |
| 09/04/2003 | US20030167489 For transgenic mice that produce high levels of humanizing antibodies; immunoglobulins |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166908 Seafood protein; measuring water absorption of fish bladder |
| 09/04/2003 | US20030166901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166897 Diagnosis, therapy cancer; transgenic animal |
| 09/04/2003 | US20030166877 Reducing the immunogenicity of fusion proteins |
| 09/04/2003 | US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 09/04/2003 | US20030166875 Fibroblast growth factor homologous factor-2 and methods of use |
| 09/04/2003 | US20030166874 Induce fibrin deposits in tumor; antitumor agents |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 09/04/2003 | US20030166871 Grafting; forming libraries; anticancer agents |
| 09/04/2003 | US20030166870 Detection sensitivity to virus; administering binding antibody; measurement; calibration; viricides |
| 09/04/2003 | US20030166869 Chromatography separation using apatite |
| 09/04/2003 | US20030166868 Detecting binding; measurement; calibration |
| 09/04/2003 | US20030166864 Controlling immunology; antiinflammatory agents |
| 09/04/2003 | US20030166862 Purified mammalian CTLA-8 antigens and related reagents |
| 09/04/2003 | US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 09/04/2003 | US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin |
| 09/04/2003 | US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections |
| 09/04/2003 | US20030166832 Methods and compositions for impairing multiplication of HIV-1 |
| 09/04/2003 | US20030166589 Method and pharmaceutical composition for the treatment of multiple sclerosis |
| 09/04/2003 | US20030166587 Compounds and methods for modulating activation of NF-kB |
| 09/04/2003 | US20030166565 CD antigens; for regulating inflammation; nuclear magnetic resonance; drug screening |
| 09/04/2003 | US20030166551 For inhibiting expression of adhesion molecules in vascular endothelial cells comprising adipose tissue-specific secretory factor |
| 09/04/2003 | US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions. |
| 09/04/2003 | US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation. |
| 09/04/2003 | US20030166521 Inhibition of thrombosis by treatment with P-selectin antagonists |
| 09/04/2003 | US20030166518 Characterization of allergens using recombinant fusion protein in an enzyme-linked immunosorbent (ELISA) assay. Also disclosed are methods for determining allergen sensitivity and methods for immunotherapy using the ELISA of the present |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 09/04/2003 | US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/04/2003 | US20030166228 Anti-interferon-alpha antibodies |
| 09/04/2003 | US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells |
| 09/04/2003 | US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK) |
| 09/04/2003 | US20030166210 Polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the treatment of cognitive and |
| 09/04/2003 | US20030166196 Fusion proteins and polynucleotides encoding gelonin sequences |
| 09/04/2003 | US20030166194 Of given sequence; genetic mapping; anticoagulants |
| 09/04/2003 | US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases |
| 09/04/2003 | US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166163 Immunocytokines with modulated selectivity |
| 09/04/2003 | US20030166160 Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands |
| 09/04/2003 | US20030166158 NTR3, a novel member of the TNF-receptor supergene family |
| 09/04/2003 | US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/04/2003 | US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening |
| 09/04/2003 | US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2003 | US20030166146 Genetically engineered tissue for treating neurodegenerative diseases and bovine spongiform encephalopathy (BSE) |
| 09/04/2003 | US20030166137 Mammalian sweet and amino acid heterodimeric taste receptors |
| 09/04/2003 | US20030166132 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166102 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166101 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166100 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166098 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |
| 09/04/2003 | US20030166096 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166095 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166094 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166093 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166092 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166091 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166090 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166089 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166088 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166087 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166086 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166085 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166084 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166083 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166082 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166081 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166080 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166078 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166077 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166076 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166075 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166074 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 09/04/2003 | US20030166071 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166061 14273 receptor, a novel G-protein coupled receptor |
| 09/04/2003 | US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases |
| 09/04/2003 | US20030166033 Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type l collagen metabolites |
| 09/04/2003 | US20030166032 Measuring unmineralized collagen/telopeptides in vivo via detecting antibody binding |
| 09/04/2003 | US20030166031 Assay for anti-INGAP antibodies |
| 09/04/2003 | US20030166029 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |